Cancers (May 2022)

Lymph Nodes as Anti-Tumor Immunotherapeutic Tools: Intranodal-Tumor-Specific Antigen-Pulsed Dendritic Cell Vaccine Immunotherapy

  • Takashi Morisaki,
  • Takafumi Morisaki,
  • Makoto Kubo,
  • Shinji Morisaki,
  • Yusuke Nakamura,
  • Hideya Onishi

DOI
https://doi.org/10.3390/cancers14102438
Journal volume & issue
Vol. 14, no. 10
p. 2438

Abstract

Read online

Hundreds of lymph nodes (LNs) are scattered throughout the body. Although each LN is small, it represents a complete immune organ that contains almost all types of immunocompetent and stromal cells functioning as scaffolds. In this review, we highlight the importance of LNs in cancer immunotherapy. First, we review recent reports on structural and functional properties of LNs as sites for antitumor immunity and discuss their therapeutic utility in tumor immunotherapy. Second, we discuss the rationale and background of ultrasound (US)-guided intranodal injection methods. In addition, we review intranodal administration therapy of tumor-specific-antigen-pulsed matured dendritic cells (DCs), including neoantigen-pulsed vaccines.

Keywords